Mucociliary clearance in cystic fibrosis

Pediatric Pulmonology
Michael Robinson, Peter T B Bye

Abstract

Abnormal mucociliary clearance (MCC) is one of the central hypotheses for the development of lung disease in patients with cystic fibrosis (CF). However, attempts to demonstrate this decrease of MCC in vivo have proved to be somewhat less definitive, with the evidence barely favoring impaired clearance. Any apparent disparities are most likely due to the variety of methodologies used by different laboratories to measure MCC. The limitations of the various methodologies are examined in this review, in an attempt to better facilitate comparison of results. A number of physical and pharmacological therapies have been developed to promote mucus clearance from the CF airway. A summary of the results of interventional studies utilizing the measurement of MCC as an outcome measure is presented.

Associated Clinical Trials

Jul 25, 2017·Marcio Vinicius Fagundes Donadio

References

Mar 1, 1976·Journal of Applied Physiology·M B DolovichM T Newhouse
Jan 1, 1976·Archives of Disease in Childhood·D B YeatesN Aspin
Jan 1, 1991·American Journal of Respiratory Cell and Molecular Biology·R AmitaniP J Cole
Jan 1, 1990·Annual Review of Physiology·P Verdugo
Dec 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·S ShakC L Baker
Jul 1, 1989·The Journal of Clinical Investigation·P W ChengR C Boucher
Jul 1, 1989·Journal of Applied Physiology·N C MunroP J Cole
Oct 4, 1973·The New England Journal of Medicine·M L ThomsonA P Norman
Mar 29, 1973·The New England Journal of Medicine·J SanchisM Newhouse
Sep 1, 1994·The European Respiratory Journal·M L Lohmann-MatthesG Franke-Ullmann
Jul 1, 1994·American Journal of Respiratory and Critical Care Medicine·R C Boucher
Jul 1, 1994·American Journal of Respiratory and Critical Care Medicine·J A RegnisP T Bye
Feb 18, 1994·Science·C A VasconcellosT P Stossel
Sep 1, 1995·International Journal of Bio-medical Computing·T B MartonenJ S Fleming
Feb 1, 1996·American Journal of Respiratory and Critical Care Medicine·B L LaubeB J Rosenstein
May 1, 1996·American Journal of Respiratory and Critical Care Medicine·M RobinsonP T Bye
Jun 1, 1996·American Journal of Respiratory and Critical Care Medicine·W D BennettM R Knowles
Dec 1, 1995·The Journal of Clinical Investigation·Y ZhangJ F Engelhardt
Oct 1, 1996·Chest·M SalatheA Wanner
Nov 1, 1996·American Journal of Respiratory and Critical Care Medicine·P B DavisM W Konstan
Dec 1, 1996·American Journal of Respiratory and Critical Care Medicine·A WannerT G O'Riordan
Feb 1, 1997·American Journal of Respiratory and Critical Care Medicine·G G KingA J Woolcock
Mar 1, 1997·The American Journal of Physiology·J M ZahmE Puchelle
May 4, 1997·International Journal of Pediatric Otorhinolaryngology·M ArmengotJ Basterra
Dec 31, 1997·American Journal of Respiratory and Critical Care Medicine·P DiotG C Smaldone
Dec 5, 1997·The European Respiratory Journal·E A CowleyD H Eidelman
Jun 25, 1998·American Journal of Respiratory and Critical Care Medicine·J M ZahmE Puchelle
Jun 25, 1998·American Journal of Respiratory and Critical Care Medicine·T HofmannR C Boucher
Dec 31, 1998·American Journal of Respiratory Cell and Molecular Biology·D D ReesE Remold-O'Donnell

❮ Previous
Next ❯

Citations

Oct 21, 2006·Current Opinion in Pulmonary Medicine·Mark R Elkins, Peter T P Bye
Feb 22, 2012·Canadian Journal of Microbiology·Karlene H Lynch, Jonathan J Dennis
Feb 8, 2006·Annual Review of Physiology·Robert TarranRichard C Boucher
May 20, 2008·American Journal of Physiology. Lung Cellular and Molecular Physiology·Christopher S RogersMichael J Welsh
Oct 14, 2003·American Journal of Respiratory and Critical Care Medicine·Ronald L GibsonBonnie W Ramsey
Sep 5, 2009·American Journal of Respiratory and Critical Care Medicine·Patrick A FlumeUNKNOWN Clinical Practice Guidelines for Pulmonary Therapies Committee
Jul 14, 2010·American Journal of Respiratory and Critical Care Medicine·David K MeyerholzMichael J Welsh
Dec 17, 2005·American Journal of Respiratory Cell and Molecular Biology·Stephen T BallardCharles R Hamm
Oct 27, 2010·BMC Genomics·Karlene H LynchJonathan J Dennis
Dec 18, 2013·Paediatric Respiratory Reviews·Bruce K Rubin
Mar 29, 2014·Lung India : Official Organ of Indian Chest Society·Manu Kurian BabySenthil Kannan
Jan 30, 2014·Proceedings of the National Academy of Sciences of the United States of America·Mark J HoeggerMichael J Welsh
Mar 17, 2015·Expert Review of Anti-infective Therapy·Vikas GautamAmit Agarwal
Mar 17, 2011·Expert Review of Molecular Diagnostics·Geraint B RogersKenneth D Bruce
Jun 24, 2009·Expert Opinion on Biological Therapy·I A PringleD R Gill
Feb 3, 2015·Expert Opinion on Drug Delivery·Mareike Klinger-StrobelOliwia Makarewicz
Aug 6, 2004·Journal of Pharmaceutical Sciences·Ronald J PettisAnthony J Hickey
Jan 26, 2016·The Journal of Clinical Investigation·Xiao Xiao TangMichael J Welsh
Jan 30, 2010·The American Journal of Pathology·David K MeyerholzMichael J Welsh
Jun 12, 2013·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Hayley HolmesKylie Hill
Apr 11, 2007·Paediatric Respiratory Reviews·Peter T P Bye, Mark R Elkins
Feb 27, 2007·Biochimica Et Biophysica Acta·Niek N SandersJoseph Demeester
Nov 4, 2015·Frontiers in Microbiology·Srinivasan Chinnapaiyan, Hoshang J Unwalla
Nov 18, 2003·British Journal of Clinical Pharmacology·N R Labiris, M B Dolovich
Sep 11, 2013·Pediatric Pulmonology·Margarita PérezAlejandro Lucia
Feb 14, 2006·Paediatric Respiratory Reviews·Marina Buarque de AlmeidaJoaquim Carlos Rodrigues
Jun 15, 2011·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Franziska A StressmannKenneth D Bruce
May 26, 2005·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Uta GriesenbachUNKNOWN UK Cystic Fibrosis Gene Therapy Consortium
Nov 25, 2014·Cellular and Molecular Life Sciences : CMLS·Brendan K Huang, Michael A Choma
Jan 22, 2015·The New England Journal of Medicine·David A StoltzMichael J Welsh
Jul 25, 2014·Medical Mycology·Maria NoniChryssa Tzoumaka-Bakoula
Feb 13, 2010·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·G B RogersK D Bruce
Sep 30, 2010·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·G Greub
Jul 9, 2016·JCI Insight·Mahmoud H Abou AlaiwaJoseph Zabner
Nov 5, 2016·JCI Insight·Gregg A DuncanJung Soo Suk
Jun 29, 2017·International Forum of Allergy & Rhinology·Kiranya E TipirneniBradford A Woodworth
Apr 30, 2008·Journal of Intensive Care Medicine·Ted M KremerP O'Sullivan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.